Much of what is claimed about extending life traces back to experiments in worms, flies and mice. The step from those results to a human recommendation crosses several gaps that the headline version usually omits.
Short-lived species are chosen for practicality
A laboratory worm lives a few weeks and a mouse a few years, which is what makes lifespan experiments possible at all.
The same short lifespan means these animals have evolved under very different pressures, with far less investment in long-term repair than a species living for decades.
An intervention that improves repair in an organism with little of it may add proportionally less where those systems are already extensive.
Laboratory conditions remove most causes of death
Housed animals are protected from predation, cold, infection and food scarcity, and are usually genetically near-identical.
Under those conditions almost all variation in lifespan comes from internal ageing processes, which is precisely what makes an effect easy to detect.
Human populations lose years to accident, infection, occupational exposure and disease driven by variable genetics, so an equivalent internal effect is diluted.
Control diets shape the size of the effect
Many lifespan extensions are measured against animals given unrestricted access to food, which tend to become heavy and short-lived.
Restricting intake in that setting partly corrects an artefact of the housing rather than revealing a general rule about eating less.
When control animals are fed more moderately from the start, the extension from further restriction usually shrinks and sometimes disappears.
Effects often fail to replicate across strains
Compounds that extend life in one mouse strain frequently produce a smaller effect, or none, in another, and results sometimes differ by sex.
Coordinated programmes that test candidate compounds across multiple sites and genetic backgrounds were set up precisely because single-laboratory results proved fragile.
A finding that survives that process is far stronger evidence than one reported from a single colony, and very few candidates have survived it.
Why human confirmation is so slow
Testing a lifespan claim directly in people would require decades of follow-up, so trials instead use intermediate markers such as blood measures or immune response.
Those markers stand in for the outcome, and a change in a marker has repeatedly failed to predict a change in survival in other areas of medicine.
This is why animal results should be read as reasons to investigate rather than as established human effects, and why anyone considering a compound for this reason needs medical supervision.